What's coming to Contemporary OBGYN® this week?
Alabama’s attorney general retracted comments he made last week suggesting criminal prosecution for women taking abortion pills for pregnancy termination. He is now saying that only providers who prescribe the pills could be prosecuted.
If approved, DARE-HRT1 would become the first FDA-approved monthly intravaginal ring to deliver both estrogen and progestin hormone therapy.
In this month's Legally Speaking column, Hindi Stohl, MD, JD, and James M. Shwayder, MD, JD, dissect a case of shoulder and abdominal dystocia during a vaginal delivery for fetal hydrops.
Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.
Results of a study in JAMA Network Open sought to answer the question: Is proton pump inhibitor use during pregnancy associated with an increased risk of congenital malformations?
Many couples experiencing infertility are hesitant to get vaccined for COVID-19, resulting from misinformation on social media. A research letter in JAMA Network Open investigates the impact of COVID-19 vaccinations on artificial insemination-by-partner outcomes.
Check back soon for additional updates!
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More